WHO publishes analysis of patent situation of new hepatitis treatments

Source: World Health Organization

Resolution WHA67.6 requested the Director-General to assist Member States in ensuring equitable access to quality, effective, affordable and safe HCV treatments. For governments to identify ways of increasing access and affordability to these treatments, clarity about whether the medicines are patent protected in the respective countries is needed. Assessing the patent situation requires expert knowledge and access to specialized databases. Therefore, to assist countries in this endeavor, the WHO Secretariat has mandated Thomson Reuters to carry out an analysis of the patent situation of seven new hepatitis treatments.

The working papers can be accessed here

This entry was posted in Hepatitis C, WHO, World Health Assembly. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s